Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kumiko eNakada-Tsukui"'
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Entamoeba histolytica is a protozoan parasite and the causative agent of amebiasis. It is estimated approximately 1% of humans are infected with E. histolytica, resulting in an estimate of 100,000 deaths annually. Clinical manifestations of amebic in
Externí odkaz:
https://doaj.org/article/fddfdae1091d49138d90218e9a31976a
Autor:
Mihoko eMori, Ghulam eJeelani, Yui eMasuda, Kazunari eSakai, Kumiko eNakada-Tsukui, Danang eWaluyo, Tarwadi e_, Yoshio eWatanabe, Kenichi eNonaka, Atsuko eMatsumoto, Satoshi eŌmura, Tomoyoshi eNozaki, Kazuro eShiomi
Publikováno v:
Frontiers in Microbiology, Vol 6 (2015)
Amebiasis is a common worldwide diarrheal disease, caused by the protozoan parasite, Entamoeba histolytica. Metronidazole has been a drug of choice against amebiasis for decades despite its known side effects and low efficacy against asymptomatic cys
Externí odkaz:
https://doaj.org/article/7da44b7355b84d5e86fa1146dc4cd3d4
Publikováno v:
Frontiers in Microbiology, Vol 6 (2015)
Antimicrobial chemotherapy is critical in the fight against infectious diseases caused by Entamoeba histolytica. Among the drugs available for the treatment of amebiasis, metronidazole (MTZ) is considered the drug of choice. Recently, in vitro studie
Externí odkaz:
https://doaj.org/article/4d3e18f4655d46e0b10cc4b848fbe97b